Mari Yoshida
Mari Yoshida publishes mostly in Neurology, Molecular Biology and Neurology, on topics such as Parkinson's Disease Mechanisms and Treatments, Neurological diseases and metabolism and Amyotrophic Lateral Sclerosis Research.
- World rank
- #1,002,874 of 7,710,434 ranked researchers
- Rank in Japan
- #13,496 of 383,136
- Works
- 480
- Citations
- 21k
- Citations per work
- 43.0
What does Mari Yoshida research?
Mari Yoshida's work is mostly in Medicine (38%), Neuroscience (17%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences18137.7%
- Medicine18137.7%
- Everything else15231.6%
- Life Sciences14730.7%
- Neuroscience8317.2%
- Biochemistry, Genetics and Molecular Biology6513.5%
- 1Neurology27% of their works
- 2Molecular Biology14% of their works
- 3Neurology9% of their works
- 4Cellular and Molecular Neuroscience8% of their works
- 5Physiology7% of their works
- 6Psychiatry and Mental health4% of their works
Research topics
- Parkinson's Disease Mechanisms and Treatments
- Neurological diseases and metabolism
- Amyotrophic Lateral Sclerosis Research
- Alzheimer's disease research and treatments
- Prion Diseases and Protein Misfolding
- Genetic Neurodegenerative Diseases
- Neurological disorders and treatments
- Neurogenetic and Muscular Disorders Research
Which keywords describe Mari Yoshida's research?
The keywords of their largest research topics: Neurodegeneration, Mitochondrial Dysfunction, Oxidative Stress, Parkinson's Disease, Protein Aggregation, a-Synuclein, Dopaminergic Neurons and Brain Iron Accumulation.
- SMN1
- Deep Brain Stimulation
- Huntington's Disease
- Molecular Basis
- Amyloid Hypothesis
- FUS/TLS
- Brain Iron Accumulation
- Dopaminergic Neurons
- Parkinson's Disease
- Mitochondrial Dysfunction
- Neurodegeneration
- Oxidative Stress
- Protein Aggregation
- a-Synuclein
- Pantothenate Kinase
- TDP-43
- Tau Pathology
- Prion Diseases
- Polyglutamine
- Subthalamic Nucleus
- Spinal Muscular Atrophy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Neurodegeneration3894 topics
- Mitochondrial Dysfunction2973 topics
- Oxidative Stress2042 topics
- Parkinson's Disease1602 topics
- Protein Aggregation1502 topics
- Dopaminergic Neurons1241 topic
- a-Synuclein1241 topic
- Brain Iron Accumulation991 topic
- Pantothenate Kinase991 topic
- FUS/TLS861 topic
- TDP-43861 topic
- Amyloid Hypothesis801 topic
- Tau Pathology801 topic
- Molecular Basis761 topic
- Prion Diseases761 topic
- Huntington's Disease741 topic
- Polyglutamine741 topic
- Deep Brain Stimulation361 topic
- Subthalamic Nucleus361 topic
- SMN1281 topic
- Spinal Muscular Atrophy281 topic
Where does Mari Yoshida work?
Mari Yoshida's main affiliation in the publication record is Aichi Medical University, Japan.
How many publications and citations does Mari Yoshida have?
OpenAlex counts 480 works and 20,663 citations for Mari Yoshida, an h-index of 66, ranking #1,002,874 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Mari Yoshida
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mari Yoshida. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.